Artificial Intelligence

Kia unveils an ambitious roadmap for exponential growth, detailing a massive investment in EVs, hybrids, autonomous tech, and robotics to reshape its future.

A new paper warns that Lyme disease may pass from mother to child, a risk overlooked for decades. Researchers are now demanding urgent action and funding.

Certes launches v7, a new platform offering quantum-safe data protection in days, securing legacy apps and edge devices against future 'Q-Day' threats.

Wizzmoni's new AI-powered machine promises gold loans in 20 minutes, aiming to disrupt India's traditional lending market and boost financial inclusion.

A new report reveals finance professionals who own crypto are far more optimistic and see less risk than their peers, pointing to a maturing market.

Swedish cyber firm Advenica launches a physical kiosk to scan and neutralize malware on USB drives, tackling a persistent threat to critical networks.

Sunon's CIFF 2026 showcase reveals a future where recyclable furniture, modular layouts, and robotic guides shape a smarter, greener, human-centric workplace.

Optro's inaugural EMEA conference signals a major push into Europe's complex GRC market, focusing on AI governance and transforming risk into opportunity.

A new partnership between Infocentric and Shipsy brings AI-native logistics to the Philippines, aiming to solve island-chain challenges and power a digital economy.

Satri-cel, the world's first CAR-T therapy for solid tumors, is set to launch in China, offering a powerful new weapon against advanced stomach cancers.

Aptar Digital Health and Enable Injections are pairing the enFuse® wearable injector with a new digital app to transform self-care for chronic diseases.

New Era Energy & Digital secures a massive $290M loan from Macquarie to build a 1+ GW AI campus, turning the energy-rich Permian Basin into a digital hub.

With its reputation on the line, SF's top leaders are gathering for IDEASF, a new forum aiming to spark a city-wide renaissance. But can it deliver results?

As Watts Water Technologies preps its Q1 2026 report, investors watch for clues on market health, strategic growth, and the impact of new regulations.

A little-known platform rocketed from $420k to $1.5B in three years. We explore the powerful tech engine behind this explosive rise in wealth management.

The deal merges a leading health data platform with mobile diagnostics, aiming to remove barriers to proactive wellness and deliver lab tests anywhere.

Jordan Foster Construction's latest award reveals a deeper trend: integrating mental health and AI to redefine safety in a high-risk industry.

With its lead drug in Phase 3 and a strong Biogen partnership, Stoke Therapeutics prepares to update investors on its disease-modifying Dravet syndrome therapy.

A new study reveals why GLP-1 drugs work for some and not others. 23andMe's research could personalize obesity treatment for millions of patients.

A single-dose therapy wiped out aggressive glioblastoma tumors in a landmark pre-clinical study, paving the way for human trials in 2026.